Again, our results confirm the high levels of IL-6 and IL-8 in NSCLC patients; however, no differences were seen between our cohorts in IL-12p70 or IFNγ concentrations, and IL-17A was found to be lower in our NSCLC group. The gene discussed is IL6; the disease is non-small cell lung carcinoma.